75F40124F19001↗

Vets Synergetic Group LLC received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $3.19M obligated so far for support- management: other. It runs to 2027-07-23.

Key facts · data as of Oct 25, 2026

Recipient
Vets Synergetic Group LLC
Awarding agency
Food and Drug Administration (Department of Health and Human Services)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Obligated to date
$3.19M
Potential value
$3.22M
Ends
2027-07-23

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award 75F40124F19001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75F40124F19001_7524_75F40124D00020_7524

TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.

Delivery Order · Food and Drug Administration · to Vets Synergetic Group LLC (UEI CKT7ALMJZL25) · data as of 2026-10-25

Obligated to date$3.19M6 actions
Current value$3.19Mwith options exercised
Potential value$3.22Mif every option is used
Period2024-07-02 → 2027-07-23current end date

Up for re-bid: ends 2027-07-23. Recompete brief →

What it is

Product or service
Support- Management: Other (PSC R799)
Industry
All Other Professional, Scientific, and Technical Services (NAICS 541990)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Competition
Competed under simplified acquisition
Pricing
Labor hours
How it was bought
Single-award IDIQ · under 75F40124D00020
Where the work is
Montgomery, MD · district MD-08

Obligations by fiscal year

FY2024$1.31M
FY2025$1.14M
FY2026$745.0K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

6 actions since 2024-07-02. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2026-06-18P00005Option exercised$745.0KTO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS-EXERCISE OP2 AND MODIFY OP2 POP.
2026-04-14P00004Administrative change$0TO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA'S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS.
2025-07-21P00003Option exercised$1.14MMODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025 AND EXERCISE OY1
2024-12-10P00002Administrative change$0NO COST MODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025.
2024-11-04P00001Administrative change$0NO COST MODIFICATION TO CHANGE PERIOD OF PERFORMANCE END DATE TO SEPTEMBER 30, 2025.
2024-07-020$1.31MTO OBTAIN 7 SCIENTIFIC CONTRACT PROFESSIONALS TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR DRUG EVALUATION AND RESEARCH, OFFICE OF BIOTECHNOLOGY PRODUCTS UNDER IDIQ CONTRACT 75F40124D00020.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗